Stocktoria
ALUMIS INC. ALMS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2024-06-28
ALUMIS INC. statistics & valuation
Market cap$3.4B
P / B11.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Operating margin | -1886.9% | — | — |
| Net margin | -1011.7% | — | — |
| FCF margin | -1539.2% | — | — |
| Return on assets | -59.1% | -86.3% | -173.0% |
| Return on equity | -80.8% | -113.1% | 45.7% |
| Current ratio | 4.34 | 6.01 | 2.56 |
Source: SEC EDGAR filings · CIK 0001847367 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.